| ²é¿´: 2322 | »Ø¸´: 3 | ||||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷ÕßÊǸöºÃÓ°ÃÔ½«ÔùËÍÄú 5 ¸ö½ð±Ò | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
ÊǸöºÃÓ°ÃÔÌú³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇëÎÊelsevierÕâ¸örevise-language״̬ÊÇÐèÒª´óÐÞÂ𣿠ÒÑÓÐ3È˲ÎÓë
|
|||
|
ͶÁËÒ»¸öÈýÇøÎÄÕÂÏÖÔÚµÚ¶þ´Î´óÐÞµÄÒâ¼û·µ»ØView DecisionµÄ״̬ÊÇrevise-language£¬µ«ÊǸøÁËÁ½¸öÔ¡£ ±à¼µÄÒâ¼ûÊÇ£º Reviewer comments on your manuscript indicated that it is not acceptable for publication in its present form. However, I invite you to submit a revised version of your manuscript if you feel that you can suitably address the reviewers' comments included below. If you submit a revised manuscript, please consider the reviewer's comments carefully. Please resubmit your manuscript by Nov 28, 2022. È»ºóÖ±½ÓÌùÁËÁ½¸öÆÀÉóµÄÆÀ·Ö±í¸øÎÒ£º 1. Are the objectives and the rationale of the study clearly stated? Reviewer #1: The objectives and the rationale are clearly described. Reviewer #3: 1¡¢well stated -------------------- 2. If applicable, is the application/theory/method/study reported in sufficient detail to allow for its replicability and/or reproducibility? Reviewer #1: Mark as appropriate with an X: Yes [X] No [] N/A [] Provide further comments here: Reviewer #3: Mark as appropriate with an X: Yes [X] No [] N/A [] Provide further comments here: -------------------- 3. If applicable, are statistical analyses, controls, sampling mechanism, and statistical reporting (e.g., P-values, CIs, effect sizes) appropriate and well described? Reviewer #1: Mark as appropriate with an X: Yes [X] No [] N/A [] Provide further comments here: Reviewer #3: Mark as appropriate with an X: Yes [X] No [] N/A [] Provide further comments here: -------------------- 4. Could the manuscript benefit from additional tables or figures, or from improving or removing (some of the) existing ones? Please provide specific suggestions for improvements, removals, or additions of figures or tables. Please number each suggestion so that author(s) can more easily respond. Reviewer #1: Tables and figures are fine. Reviewer #3: the results had been well stated. -------------------- 5. If applicable, are the interpretation of results and study conclusions supported by the data? Reviewer #1: Mark as appropriate with an X: Yes [X] No [] N/A [] Provide further comments here: Reviewer #3: Mark as appropriate with an X: Yes [] No [] N/A [X] Provide further comments here: -------------------- 6. Have the authors clearly emphasized the strengths of their study/theory/methods/argument? Reviewer #1: They clearly described their strength of the study, Reviewer #3: No. highlights had not been well emphasized. -------------------- 7. Have the authors clearly stated the limitations of their study/theory/methods/argument? Reviewer #1: Yes, they clearly mentioned the limitation. Reviewer #3: 1. should be further analyzed in this research. -------------------- 8. Does the manuscript structure, flow or writing need improving (e.g., the addition of subheadings, shortening of text, reorganization of sections, or moving details from one section to another)? Reviewer #1: The structure of the paper is fine, Reviewer #3: 1. The logical meaning of some sentence are confusing,£» such as "Hence, .... efficiency and usability." 2. there were a fair amount of grammatical errors found in this manuscript. -------------------- 9. Could the manuscript benefit from language editing? Reviewer #1: No Reviewer #3: Yes Ö÷ÒªÊÇÆÀÉó3ÌáÁË¢ÙhighlightдµÃ²»¹»ºÃ£¬¢Ú½á¹ûÐèÒª½øÒ»²½·ÖÎö£¬¢ÛÌáÁËÒ»¸öÓï·¨ÎÊÌ⵫ÈÏΪÎÄÕÂÐèÒªÈóÉ« ÆäʵÎÒ¶þÉóÒѾÈóÉ«¹ýÁË£¬²¢ÇÒ¸½ÉÏÁËelsevierµÄÓïÑÔ±à¼Ö¤Ê飬ÆÀÉó1¾õµÃÓïÑÔûÎÊÌ⣬ÆÀÉó3¾õµÃÓÐÎÊÌ⠹ؼü±à¼Õâ¾äit is not acceptable for publication in its present formÊÇÌ×»°»¹ÊÇίÍñµÄ¾Ü¸å..... |
» ²ÂÄãϲ»¶
³É¹ûϵͳ·ÃÎÊÁ¿´ó£¬Çë15·ÖÖÓºóÔÙ³¢ÊÔ¡£Óɴ˸øÄúÔì³ÉµÄ²»±ã£¬¾´ÇëÁ½⡣
ÒѾÓÐ18È˻ظ´
ÊÛäÂSCIÎÄÕ£¬ÎÒ:8¡Ñ 55 1¡Ñ 54¡£±¸×¢¡¾¡Ñ=0¡¿
ÒѾÓÐ4È˻ظ´
ÊÛäÂSCIÎÄÕ£¬ÎÒ:8¡Ñ 55 1¡Ñ 54¡£±¸×¢¡¾¡Ñ=0¡¿
ÒѾÓÐ5È˻ظ´
ÊÛäÂSCIÎÄÕ£¬ÎÒ:8¡Ñ 55 1¡Ñ 54¡£±¸×¢¡¾¡Ñ=0¡¿
ÒѾÓÐ9È˻ظ´
½ÓÊÜ26½ìµ÷¼ÁÉú
ÒѾÓÐ13È˻ظ´
µ÷¼ÁµÄͬѧ£¬×ß¹ý·¹ý£¬²»Òª´í¹ý
ÒѾÓÐ6È˻ظ´
276Çóµ÷¼Á ±¾¿ÆÌì½ò¹¤Òµ´óѧ Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ0855
ÒѾÓÐ5È˻ظ´
ÊÛäÂSCIÎÄÕ£¬ÎÒ:8¡Ñ 55 1¡Ñ 54¡£±¸×¢¡¾¡Ñ=0¡¿
ÒѾÓÐ3È˻ظ´
ÊÛäÂSCIÎÄÕ£¬ÎÒ:8¡Ñ 55 1¡Ñ 54¡£±¸×¢¡¾¡Ñ=0¡¿
ÒѾÓÐ6È˻ظ´
Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ4È˻ظ´
·çóݲ»Ïë·Éѽ
ľ³æÖ®Íõ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 651 (²©Ê¿)
- ½ð±Ò: 70731.8
- ºì»¨: 188
- ɳ·¢: 59
- Ìû×Ó: 13610
- ÔÚÏß: 742.2Сʱ
- ³æºÅ: 7065795
- ×¢²á: 2017-08-15
- ÐÔ±ð: GG
- רҵ: µç´Å³¡Ó벨

3Â¥2022-09-30 20:03:14
cyh_crl
Òø³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 53 (³õÖÐÉú)
- ½ð±Ò: 395.2
- É¢½ð: 14780
- ºì»¨: 78
- ɳ·¢: 7
- Ìû×Ó: 4212
- ÔÚÏß: 765.8Сʱ
- ³æºÅ: 1332010
- ×¢²á: 2011-06-27
- רҵ: ¹ÜÀí¿ÆÑ§ºÍ¹ÜÀí˼ÏëÊ·
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÊǸöºÃÓ°ÃÔ: ½ð±Ò+2, ¡ïÓаïÖú 2022-10-01 01:08:33
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÊǸöºÃÓ°ÃÔ: ½ð±Ò+2, ¡ïÓаïÖú 2022-10-01 01:08:33
|
it is not acceptable for publication in its present form Õâ¾ä»°Ö»ÊÇ˵Ã÷ÄãµÄÂÛÎÄÐèÒªÐ޸쬲¢ÇÒ¼¸ºõÊÇ×îÁ÷ÐеķµÐÞÄ£°å |
2Â¥2022-09-30 17:18:47
nono2009
³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)
No gains, no pains.
-

ר¼Ò¾Ñé: +21105 - SEPI: 10
- Ó¦Öú: 28684 (Ժʿ)
- ¹ó±ö: 513.911
- ½ð±Ò: 2555220
- É¢½ð: 27828
- ºì»¨: 2147
- ɳ·¢: 66666
- Ìû×Ó: 1602255
- ÔÚÏß: 65200.9Сʱ
- ³æºÅ: 827383
- ×¢²á: 2009-08-13
- ÐÔ±ð: GG
- רҵ: ¹¤³ÌÈÈÎïÀíÓëÄÜÔ´ÀûÓÃ
- ¹ÜϽ: ¿ÆÑмҳﱸίԱ»á
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÊǸöºÃÓ°ÃÔ: ½ð±Ò+2, ¡ï¡ï¡ïºÜÓаïÖú 2022-10-01 01:09:09
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÊǸöºÃÓ°ÃÔ: ½ð±Ò+2, ¡ï¡ï¡ïºÜÓаïÖú 2022-10-01 01:09:09
| °´Éó¸åÈË3µÄÒâ¼ûÔÙÐÞ¸Äһϣ¬¿´ÉÏÈ¥Ö÷ÒªÊÇÓïÑԵĸĽø¡£ |
4Â¥2022-09-30 20:56:51













»Ø¸´´ËÂ¥